Extendicare (EXETF) Stock Price, News & Analysis

Company Overview

Extendicare Inc. is a Canadian provider of healthcare and support services for seniors. The company operates long-term care homes and retirement communities, serving residents who require assisted living, complex care, rehabilitation, and other continuing-care services.

Extendicare also provides home healthcare through its ParaMed business. These services include nursing, personal support, rehabilitation, and other care delivered in patients’ homes, helping individuals maintain independence and supporting families and caregivers.

The company’s operations are primarily focused on Canada, with a presence in several provinces, including Ontario and Western Canada. Extendicare traces its roots to the late 1960s and has developed into an integrated senior-care provider. Its leadership includes President and Chief Executive Officer Dr. Michael Guerriere.

Key Stats

• Today's Range: $19.31 to $19.34
• 50-Day Range: $18.60 to $23.89
• 52-Week Range: $10.61 to $28.45
• Volume: 31,035 shs
• Average Volume: 57,615 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: 2.48%
• Price Target: N/A
• Consensus Rating: Buy

Extendicare Stock Analysis - MarketRank™

Extendicare scored higher than 16% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.9 / 5
• Analyst Rating: Buy

Consensus Rating

Extendicare has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 5 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Extendicare has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Extendicare is -74.54, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Extendicare is -74.54, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Extendicare has a short interest ratio ("days to cover") of 5.44.

Change versus previous month

Short interest in Extendicare has recently increased by 6.68%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Leadership

Extendicare is a leading dividend payer. It pays a dividend yield of 8.00%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Extendicare does not have a long track record of dividend growth.

News and Social Media

• Score: 2.3 / 5
• News Sentiment: N/A

News Sentiment

Extendicare has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Extendicare this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.1 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Extendicare insiders have not sold or bought any company stock.

Percentage Held by Institutions

9.44% of the stock of Extendicare is held by institutions.

Company Calendar

• Today: 10/15/2026
• Next Earnings (Estimated): 11/05/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Facilities
• Current Symbol: OTCMKTS:EXETF
• CIK: N/A
• Web: www.extendicare.com
• Phone: (905) 470-4000
• Fax: N/A
• Employees: 23,500
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A